BIOMAKERS Raises Additional $8 Million To Scale Global Precision Oncology Intelligence Platform
By Amit Chowdhry ● Yesterday at 11:23 PM
BIOMAKERS, a San Francisco-headquartered precision medicine and oncology intelligence company, announced it has closed an additional $8 million in financing as it shifts from building diagnostics and data infrastructure to scaling an AI-native platform designed to support drug and diagnostic development, improve clinical trial execution, and expand access to precision oncology globally. Participants in the round include Labcorp Venture Fund, Oncology Ventures, Endurance28, Zentynel, Sonen Capital, Sky High Fund, and other strategic investors.